aFraxis' Series B Round

aFraxis raised a round of funding on May 24, 2010. Investors include Avalon Ventures.

Afraxis is discovering and developing drugs to treat diseases of the central nervous system, including schizophrenia, Alzheimer's disease, Fragile X syndrome and autism spectrum disorders. Recent scie…

Articles about aFraxis' Series B Round: